About 653 results
Open links in new tab
  1. Tardive Dyskinesia (TD) | AUSTEDO XR® (deutetrabenazine ...

    See Prescribing Information, including Boxed Warning. Find information for healthcare professionals about once-daily AUSTEDO XR.

  2. Austedo (deutetrabenazine): Uses, Side Effects, Dosage Guide

    Aug 20, 2025 · Austedo is used to treat the involuntary movements of Huntington's disease and tardive dyskinesia (TD). Includes Austedo side effects, dosage, uses, interactions, and more

  3. Is Tardive Dyskinesia Reversible? Current Treatment Approach

    3 days ago · Tardive dyskinesia is a movement disorder caused by antipsychotics and other drugs. Though often permanent, tardive dyskinesia may be reversible with drugs like Ingrezza.

  4. AUSTEDO XR® Medication for Tardive Dyskinesia (TD)

    Once-daily AUSTEDO XR® (deutetrabenazine) extended release tablets reduce uncontrollable Tardive Dyskinesia (TD) body movements. See safety info including Boxed Warning.

  5. Tardive Dyskinesia (TD): What It Is, Symptoms & Treatment

    Tardive dyskinesia (TD) is a neurological syndrome that involves involuntary movements. Taking antipsychotic medications is the main cause of this condition.

  6. Deutetrabenazine (Austedo) - NAMI

    Generic name: Deutetrabenazine (du tet ra BEN a zeen) Brand names: Austedo® Tablets: 6 mg, 9 mg, and 12 mg Austedo XR® Tablets: 6 mg, 12 mg, and 24 mg All FDA warnings are at the …

  7. Guide to Austedo Medication Uses and Treatment Basics

    Austedo is a prescription medication used to manage certain neurological movement disorders. It is commonly prescribed for conditions such as tardive dyskinesia and Huntington disease …

  8. Tardive Dyskinesia Center of Excellence Model

    5 days ago · Credit: @McMahon Group. By Gina Shaw Five years ago, clinicians treating tardive dyskinesia (TD) had little to offer beyond dose adjustments and monitoring. Today, vesicular …

  9. Treatment Recommendations for Tardive Dyskinesia - PMC

    Tardive dyskinesia is a movement disorder characterised by irregular, stereotyped, and choreiform movements associated with the use of antipsychotic medication. We aim to provide …

  10. Lactation Risk Summary: There are no data on the presence of deutetrabenazine or its metabolites in human milk, the effects on the breastfed infant, or the effects of the drug on milk …